- Public Comps
- Lir Life Sciences
Lir Life Sciences Valuation Multiples
Discover Lir Life Sciences' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Mingteng International, American Lithium Minerals, Nyrstar, Coil and more.
Lir Life Sciences Overview
About Lir Life Sciences
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
Founded
N/A
HQ

Employees
N/A
Website
Sectors
Financials (FY)
EV
$8M
Valuation Multiples
Start free trialLir Life Sciences Financials
Lir Life Sciences reported last fiscal year revenue of - and negative EBITDA of ($302K).
In the same fiscal year, Lir Life Sciences generated ($302K) in EBITDA losses and had net loss of ($302K).
Lir Life Sciences P&L
In the most recent fiscal year, Lir Life Sciences reported revenue of - and EBITDA of ($302K).
Lir Life Sciences is unprofitable as of last fiscal year, with EBITDA margin of - and net margin of -.
Financial data powered by Morningstar, Inc.
Lir Life Sciences Stock Performance
Lir Life Sciences has current market cap of $8M, and enterprise value of $8M.
Market Cap Evolution
Lir Life Sciences' stock price is $0.29.
Lir Life Sciences share price increased by 3.9% in the last 30 days.
Lir Life Sciences has an EPS (earnings per share) of $-0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8M | $8M | 0.1% | 3.9% | -26.4% | - | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLir Life Sciences Valuation Multiples
Lir Life Sciences trades at (26.4x) EV/EBITDA.
Lir Life Sciences Financial Valuation Multiples
As of July 19, 2026, Lir Life Sciences has market cap of $8M and EV of $8M.
Lir Life Sciences has a P/E ratio of (26.3x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Lir Life Sciences Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Lir Life Sciences Competitors
Lir Life Sciences competitors include Mingteng International, American Lithium Minerals, Nyrstar, Coil, Pipe Works L Girakian, Highfield Resources, Blue Gold, Bitros Holdings, Naughty Ventures and Beowulf Mining.
Most Lir Life Sciences public comparables operate across Metals & Mining.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.8x | - | (9.6x) | - | |||
| - | - | - | - | |||
| - | - | (2.8x) | - | |||
| 0.5x | 0.5x | (8.6x) | 8.6x | |||
| - | - | - | - | |||
| - | - | - | - | |||
| - | - | (0.8x) | - | |||
| - | - | - | - | |||
This data is available for Pro users. Sign up to see all Lir Life Sciences competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Lir Life Sciences
Lir Life Sciences has acquired 1 company to date.
Last acquisition by Lir Life Sciences was on November 10th 2025. Lir Life Sciences acquired LIR life Sciences for undisclosed valuation.
Latest Acquisitions by Lir Life Sciences
| Description | LIR Life Sciences is a biopharmaceutical company developing treatments for obesity and metabolic disorders while expanding into additional therapy areas with next-generation drug candidates. |
| HQ Country | |
| HQ City | Vancouver |
| Deal Date | 10 Nov 2025 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Lir Life Sciences acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Lir Life Sciences
| Where is Lir Life Sciences headquartered? | Lir Life Sciences is headquartered in Canada. |
| Is Lir Life Sciences publicly listed? | Yes, Lir Life Sciences is a public company listed on Canadian Securities Exchange. |
| What is the stock symbol of Lir Life Sciences? | Lir Life Sciences trades under SKNY ticker. |
| When did Lir Life Sciences go public? | Lir Life Sciences went public in 2025. |
| Who are competitors of Lir Life Sciences? | Lir Life Sciences main competitors include Mingteng International, American Lithium Minerals, Nyrstar, Coil, Pipe Works L Girakian, Highfield Resources, Blue Gold, Bitros Holdings, Naughty Ventures, Beowulf Mining. |
| What is the current market cap of Lir Life Sciences? | Lir Life Sciences' current market cap is $8M. |
| Is Lir Life Sciences profitable? | No, Lir Life Sciences is not profitable. |
| How many companies Lir Life Sciences has acquired to date? | As of July 2026, Lir Life Sciences has acquired 1 company. |
| What was the largest acquisition by Lir Life Sciences? | None of the M&A deals Lir Life Sciences has completed have disclosed valuations. |
| What companies Lir Life Sciences acquired? | Lir Life Sciences acquired LIR life Sciences. |
| In how many companies Lir Life Sciences has invested to date? | Lir Life Sciences hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Lir Life Sciences
Lists including Lir Life Sciences
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.





